Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Clinical Impact of the Spatial Organization of the Immune Tumor Microenvironment in Diffuse Large B-Cell Lymphoma

Matias Autio, Suvi-Katri Leivonen, Marja-Liisa Karjalainen-Lindsberg, Teijo Pellinen, Sirpa Leppä

Blood (2023) 142 (Supplement 1): 178.

https://doi.org/10.1182/blood-2023-177893

Published: 2023

Journal Articles

Joint Analyses of Serum Proteins and Circulating Tumor DNA Improves Risk Assessment and Subtype Stratification in Large B-Cell Lymphomas

Maare Arffman, Leo Meriranta, Judit Mészáros Jørgensen, Harald Holte, Øystein Fluge, Peter de Nully Brown, Kristina Drott, Sirkku Jyrkkiö, Suvi-Katri Leivonen, Sirpa Leppä

Blood (2023) 142 (Supplement 1): 3015.

https://doi.org/10.1182/blood-2023-177849

Published: 2023

Journal Articles

Unraveling the Role and Spatial Architecture of Cancer-Associated Fibroblasts in Classical Hodgkin Lymphoma

Suvi-Katri Leivonen, Kristiina Karihtala, Marja-Liisa Karjalainen-Lindsberg, Teijo Pellinen, Sirpa Leppä

Blood (2023) 142 (Supplement 1): 4386.

https://doi.org/10.1182/blood-2023-173117

Published: 2023

Journal Articles

Serum Proteome Profiling Reveals Inflammatory, Molecular and Prognostic Information Beyond the Ctdna in Aggressive B-Cell Lymphomas

Maare Arffman, Leo Meriranta, Harald Holte, Judit Jørgensen, Peter De Nully Brown, Sirkku Jyrkkio, Mats Jerkeman, Øystein Fluge, Magnus Björkholm, Matias Autio, Suvi-Katri Leivonen, Sirpa Leppa

Blood (2022) 140 (Supplement 1): 1316–1317.

https://doi.org/10.1182/blood-2022-158426

Published: 2022

Journal Articles

Characterization and Clinical Impact of the Tumor Microenvironment of Post-Transplant Large B-Cell Lymphoma

Suvi-Katri Leivonen, Terhi Friman, Samuli Vaittinen, Andreas Wind Jensen, Francesco Annibale d'Amore, Stephen Jacques Hamilton-Dutoit, Harald Holte, Klaus Beiske, Panu Kovanen, Riikka Räty, Sirpa Leppa

Blood (2022) 140 (Supplement 1): 6434–6435.

https://doi.org/10.1182/blood-2022-155860

Published: 2022

Journal Articles

Tumor Microenvironment and It's Prognostic Value Is Different in Testicular and Systemic Diffuse Large B-Cell Lymphoma

Marjukka Pollari, Matias Autio, Oscar Brück, Teijo Pellinen, Suvi-Katri Leivonen, Sirpa Leppa

Blood (2022) 140 (Supplement 1): 3573–3574.

https://doi.org/10.1182/blood-2022-156042

Published: 2022

Journal Articles

The Composition, Cell Interaction Patterns and Prognostic Impact of the Tumor Microenvironment in Germinal Center B-Cell and Activated B-Cell-like Diffuse Large B-Cell Lymphoma

Matias Autio, Suvi-Katri Leivonen, Oscar Brück, Marja-Liisa Karjalainen-Lindsberg, Teijo Pellinen, Sirpa Leppa

Blood (2022) 140 (Supplement 1): 3568–3569.

https://doi.org/10.1182/blood-2022-158431

Published: 2022

Journal Articles

Clinical Impact of Tumor-Associated Macrophage and T-Cell Contents in Diffuse Large B-Cell Lymphoma

Matias Autio, MD, Suvi-Katri Leivonen, PhD, Teijo Pellinen, PhD, Sirpa Leppa, MD PhD

Blood (2020) 136 (Supplement 1): 33.

https://doi.org/10.1182/blood-2020-142331

Published: 2020

Journal Articles

Molecular Profiling of Aggressive Non-Hodgkin Lymphoma - Results from a Phase 1/2 Preben Study

Suvi-Katri Leivonen, PhD, Judit Jørgensen, MD PhD, Thomas Stauffer Larsen, MD PhD, Annika Pasanen, MD PhD, Marja-Liisa Karjalainen-Lindsberg, MD PhD, Helle M Toldbod, PhD, Francesco d'Amore, MD PhD, Sirpa Leppa, MD PhD

Blood (2019) 134 (Supplement_1): 5314.

https://doi.org/10.1182/blood-2019-129113

Published: 2019

Journal Articles

Tumor Microenvironment Differs between Germinal Centre B-Cell and Non-Germinal Centre B-Cell like Diffuse Large B-Cell Lymphomas and Has Subtype-Specific Prognostic Impact on Survival

Matias Autio, Suvi-Katri Leivonen, PhD, Marja-Liisa Karjalainen-Lindsberg, MD PhD, Teijo Pellinen, PhD, Sirpa Leppa, MD PhD

Blood (2019) 134 (Supplement_1): 5230.

https://doi.org/10.1182/blood-2019-129681

Published: 2019

Journal Articles

Immunogenomic Landscape of Hematological Malignancies

Olli Dufva, Petri Pölönen, MSc, Oscar Brück, MD, Mikko A Keränen, MD PhD, Juha Mehtonen, MSc, Sanna M. Siitonen, MD PhD, Suvi-Katri Leivonen, PhD, Leo Meriranta, MS, Sirpa Leppa, MD Prof, Matti Nykter, Olli Lohi, MD PhD, Merja Heinäniemi, PhD, Satu Mustjoki, MD PhD

Blood (2018) 132 (Supplement 1): 2596.

https://doi.org/10.1182/blood-2018-99-118335

Published: 2018

Journal Articles

Th1/2 Immune Response Signature Predicts Outcome after Dose-Dense Immunochemotherapy in Patients with High Risk Diffuse Large B-Cell Lymphoma - Results from Nordic Lymphoma Group Trials

Matias Autio, Suvi-Katri Leivonen, PhD, Judit Mészáros Jørgensen, Marja-Liisa Karjalainen-Lindsberg, Klaus Beiske, Harald Holte, Sirpa Leppa, MD

Blood (2017) 130 (Supplement 1): 4008.

https://doi.org/10.1182/blood.V130.Suppl_1.4008.4008

Published: 2017

Journal Articles

Characterization of Immunological Profiles with Clinical Significance in Patients with Classical Hodgkin Lymphoma

Kristiina Karihtala, Suvi-Katri Leivonen, PhD, Marja-Liisa Karjalainen-Lindsberg, Sirpa Leppa, MD

Blood (2017) 130 (Supplement 1): 4015.

https://doi.org/10.1182/blood.V130.Suppl_1.4015.4015

Published: 2017

Journal Articles

Low Expression of T/NK-Cell Signature Predicts Poor Survival in Patients with Primary Testicular and Diffuse Large B-Cell Lymphoma

Suvi-Katri Leivonen, PhD, Marjukka Pollari, MD, Oscar Brück, Teijo Pellinen, PhD, Marja-Liisa Karjalainen-Lindsberg, Susanna Mannisto, MD PhD, Pirkko-Liisa Kellokumpu-Lehtinen, MD prof, Satu Mustjoki, MDPhD, Sirpa Leppa, MD

Blood (2017) 130 (Supplement 1): 4027.

https://doi.org/10.1182/blood.V130.Suppl_1.4027.4027

Published: 2017

Journal Articles

High Amount of PD-L1+ Tumor Associated Macrophages Is Associated with Better Survival in Patients with Primary Testicular Lymphoma

Marjukka Pollari, MD, Oscar Brück, Suvi-Katri Leivonen, PhD, Teijo Pellinen, PhD, Pauli Vähämurto, Marja-Liisa Karjalainen-Lindsberg, Susanna Mannisto, MD PhD, Pirkko-Liisa Kellokumpu-Lehtinen, MD prof, Satu Mustjoki, MDPhD, Sirpa Leppa, MD

Blood (2017) 130 (Supplement 1): 2761.

https://doi.org/10.1182/blood.V130.Suppl_1.2761.2761

Published: 2017

Journal Articles

Characterization of the Microrna Expression Profiles of Paired Primary and Relapsed Diffuse Large B-Cell Lymphoma (DLBCL) By Next-Generation Sequencing

Suvi-Katri Leivonen, PhD, Katherine Icay, MSc, Chengyu Liu, MSc, Minna Taskinen, PhD, Rainer Lehtonen, PhD, Marja-Liisa Karjalainen-Lindsberg, MD PhD, Jan Delabie, MD PhD, Harald Holte, MD PhD, Sampsa Hautaniemi, PhD, Sirpa Leppä, MD PhD

Blood (2014) 124 (21): 1626.

https://doi.org/10.1182/blood.V124.21.1626.1626

Published: 2014

NARROW

Clinical Impact of the Spatial Organization of the Immune Tumor Microenvironment in Diffuse Large B-Cell Lymphoma

Joint Analyses of Serum Proteins and Circulating Tumor DNA Improves Risk Assessment and Subtype Stratification in Large B-Cell Lymphomas

Unraveling the Role and Spatial Architecture of Cancer-Associated Fibroblasts in Classical Hodgkin Lymphoma

Serum Proteome Profiling Reveals Inflammatory, Molecular and Prognostic Information Beyond the Ctdna in Aggressive B-Cell Lymphomas

Characterization and Clinical Impact of the Tumor Microenvironment of Post-Transplant Large B-Cell Lymphoma

Tumor Microenvironment and It's Prognostic Value Is Different in Testicular and Systemic Diffuse Large B-Cell Lymphoma

The Composition, Cell Interaction Patterns and Prognostic Impact of the Tumor Microenvironment in Germinal Center B-Cell and Activated B-Cell-like Diffuse Large B-Cell Lymphoma

Clinical Impact of Tumor-Associated Macrophage and T-Cell Contents in Diffuse Large B-Cell Lymphoma

Molecular Profiling of Aggressive Non-Hodgkin Lymphoma - Results from a Phase 1/2 Preben Study

Tumor Microenvironment Differs between Germinal Centre B-Cell and Non-Germinal Centre B-Cell like Diffuse Large B-Cell Lymphomas and Has Subtype-Specific Prognostic Impact on Survival

Immunogenomic Landscape of Hematological Malignancies

Th1/2 Immune Response Signature Predicts Outcome after Dose-Dense Immunochemotherapy in Patients with High Risk Diffuse Large B-Cell Lymphoma - Results from Nordic Lymphoma Group Trials

Characterization of Immunological Profiles with Clinical Significance in Patients with Classical Hodgkin Lymphoma

Low Expression of T/NK-Cell Signature Predicts Poor Survival in Patients with Primary Testicular and Diffuse Large B-Cell Lymphoma

High Amount of PD-L1+ Tumor Associated Macrophages Is Associated with Better Survival in Patients with Primary Testicular Lymphoma

Characterization of the Microrna Expression Profiles of Paired Primary and Relapsed Diffuse Large B-Cell Lymphoma (DLBCL) By Next-Generation Sequencing

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only